Avience Biomedicals IPO: Check GMP, price band and other details

Avience Biomedicals is launching an SME IPO worth Rs 30.24 crore, comprising a fresh issue of 14,53,800 shares with no offer-for-sale component. The grey market premium stood at 36 percent ahead of the opening, implying an unofficial market price of around Rs 283 against the upper price band, indicating strong pre-listing demand. The company, which manufactures molecular diagnostic solutions and IVD products, plans to use proceeds towards a new manufacturing unit and working capital requirements.